Question · asked by 1 review
Combined deferasirox and deferiprone vs deferiprone: Mortality at any time point
- Population
- people with transfusion‐dependent thalassemia
- Intervention
- Combined deferasirox and deferiprone
- Comparison
- deferiprone
- Outcome
- Mortality at any time point
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Combined deferasirox and deferiprone vs deferiprone alone Mortality at any time point · people with transfusion‐dependent thalassemia Deferasirox for managing iron overload in people with thalassaemia (2017) · Cochrane Headline outcomes only | no estimate extracted | 1 participants | GRADE not reported |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Deferasirox for managing iron overload in people with thalassaemia 2017 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
Related questions
The same intervention and outcome, asked in another population or against another comparator.
- Combined deferasirox and deferiprone vs deferiprone and deferoxamine · people with transfusion‐dependent thalassemia · 1 review
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.